Selected article for: "immune system and myeloid cell"

Author: Pant, Ayush; Medikonda, Ravi; Lim, Michael
Title: Alternative Checkpoints as Targets for Immunotherapy
  • Cord-id: ty3wo4o3
  • Document date: 2020_11_3
  • ID: ty3wo4o3
    Snippet: PURPOSE OF REVIEW: Immunotherapy has shown an unprecedented response in treatment of tumors. However, challenges such as lack of cytotoxic lymphocytes to mount an immune response or development of resistance to therapy can limit efficacy. Here, we discuss alternative checkpoints that can be targeted to improve cytotoxic lymphocyte function while harnessing other components of the immune system. RECENT FINDINGS: Blockade of alternative checkpoints has improved anti-tumor immunity in mouse models
    Document: PURPOSE OF REVIEW: Immunotherapy has shown an unprecedented response in treatment of tumors. However, challenges such as lack of cytotoxic lymphocytes to mount an immune response or development of resistance to therapy can limit efficacy. Here, we discuss alternative checkpoints that can be targeted to improve cytotoxic lymphocyte function while harnessing other components of the immune system. RECENT FINDINGS: Blockade of alternative checkpoints has improved anti-tumor immunity in mouse models and is being tested clinically with encouraging findings. In addition to modulating T cell function directly, alternative checkpoints can also regulate activity of myeloid cells and regulatory T cells to affect anti-tumor response. SUMMARY: Combination of immune checkpoint inhibitors can improve treatment of tumors by activating multiple arms of the immune system.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and adjuvant vaccine: 1
    • action mechanism and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • action mechanism and lymph node: 1, 2, 3
    • activation proliferation and adjuvant vaccine: 1
    • activation proliferation and lung cancer: 1
    • activation proliferation and lymph node: 1
    • adjuvant vaccine and local delivery: 1
    • adjuvant vaccine and lymph node: 1, 2
    • liver sinusoidal and lsectin liver: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • liver sinusoidal and lung cancer: 1
    • liver sinusoidal and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • liver sinusoidal endothelial cell lectin and lsectin liver: 1, 2, 3, 4, 5, 6
    • liver sinusoidal endothelial cell lectin and lung cancer: 1
    • liver sinusoidal endothelial cell lectin and lymph node: 1, 2, 3, 4, 5
    • liver sinusoidal endothelial cell lectin lsectin and lsectin liver: 1, 2, 3, 4, 5, 6
    • liver sinusoidal endothelial cell lectin lsectin and lung cancer: 1
    • liver sinusoidal endothelial cell lectin lsectin and lymph node: 1, 2, 3, 4
    • local chemotherapy and lung cancer: 1, 2, 3, 4, 5
    • local delivery and lung cancer: 1, 2, 3